背景纳米乳剂(NEs)具有稳定性好、毒性及刺激性小、载药量大及大幅度提高药物生物利用度的优点,是目前眼局部给药领域研究和应用最多的纳米给药系统之一,眼局部给药后主要经角膜途径吸收。尽管NEs具有很多物理化学和生理学优点,但其吸收分布受到角膜各层组织结构的影响。
目的观察角膜上皮和基质对眼用盐酸特比萘芬纳米乳剂(TH-NEs)经角膜途径吸收及分布的影响。
方法自乳化法制备TH-NEs,光散射粒度分析仪测定纳米乳滴的粒径及Zeta电位,高效液相色谱法(HPLC)观察TH-NEs的体外释放特征。取新西兰白兔60只,按照随机数字表法分为完整角膜组和去角膜上皮组,每组30只,其中去角膜上皮组左眼去除角膜上皮;2个组实验兔随机平均分配于5个时间点,均以左眼为实验眼。TH-NEs点实验眼,分别于给药后15、30、60、120及240 min处死动物,剖取角膜组织,HPLC法测定角膜组织中TH质量分数。以荧光素二乙酸酯(FDA)对TH-NEs进行荧光标记,取4只C57BL/6小鼠,任意取其中2只小鼠麻醉后去除左眼角膜上皮,均以左眼为实验眼,荧光标记TH-NEs点眼,双光子激光扫描共焦显微镜观察给药后30 min及60 min角膜中荧光标记TH-NEs的分布情况。
结果TH-NEs中乳滴的平均粒径为51.37 nm,Zeta电位为-0.232 7 mV;加药后12 h,药物的累积释放量为0.482%;兔眼完整角膜和去上皮角膜中药物质量分数的达峰时间均为15 min,药物的峰质量分数分别为(17.85±2.79)μg/g和(4.40±1.75)μg/g。给药后15、30、60和120 min,完整角膜中药物的平均质量分数均显著高于去上皮角膜,差异均有统计学意义( t=9.998、8.658、6.903、7.576,均 P=0.000)。给药后30 min和60 min,小鼠完整角膜中荧光标记TH-NEs均分布于角膜上皮,且角膜上皮表层荧光强度明显高于角膜上皮深层,而在去上皮角膜和完整角膜中,角膜基质内均未检测到FDA荧光。
结论TH-NEs点眼后,角膜上皮是TH-NEs经角膜途径吸收和分布的主要部位,而角膜基质层是TH-NEs向眼内扩散的主要屏障。角膜基质层可能是通过尺寸排阻作用阻碍TH-NEs的渗透。
BackgroundNanoemulsions (NEs) is one of the most popular ophthalmic colloidal drug delivery system due to its long-term stability, low toxicity and irritancy, considerable capacity for solubilization of lipophilic drug molecules and great potential in bioavailability improvement.The cornea pathway is the main route of intraocular absorption after topical use of NEs.Though NEs possess numerous physiological and physicochemical advantages, the use of NEs cannot always obtain satisfactory results.
ObjectiveThis study was to investigate the impacts of epithelium and stroma on the corneal permeation of topical ophthalmic terbinafine hydrochloride nanoemulsions (TH-NEs).
MethodsTH-NEs was prepared by the self-emulsification method.The size and Zeta potential of the oil droplets in the formulation were analyzed using a dynamic light-scattering particle size analyzer.The high performance liquid chromatography (HPLC) was used for the in vitro release study.Sixty New Zealand albino rabbits were randomly divided into intact cornea group and cornea epithelium debrided group.The cornea epithelium of the left eyes was debrided in the cornea epithelium debrided group.The TH-NEs were instilled into the lower conjunctival sac of left eyes.Six rabbits were executed from each group 15, 30, 60, 120 and 240 minutes after dosing, respectively.The corneas were collected and analyzed by HPLC.The fluorescein diacetate (FDA) was used to label the TH-NEs.Two C57BL/6 mice with left cornea epithelium debrided and 2 normal mice were used for the fluorescence tracing study.The fluorescence distribution of FDA labeled TH-NEs was observed by a two-photon laser confocal scanning microscope 30 minutes and 60 minutes after single instillation.
ResultsThe average size and Zeta potential of the oil droplets were 51.37 nm and -0.232 7 mV respectively, and 0.482% of encapsulated drugs was released from the TH-NEs after 12 hours.The peak concentrations of TH in the intact cornea and epithelium debrided cornea were (17.85±2.79)μg/g and (4.40±1.75)μg/g respectively, which occurred 15 minutes post-dose.The drug concentrations in the intact cornea were significantly higher than that in the debrided cornea 15, 30, 60 and 120 minutes after dosing, with significant differences between them ( t=9.998, 8.658, 6.903, 7.576; all at P=0.000). The fluorescence was observed in the cornea epithelium when the cornea was intact.The fluorescence intensity in the superior layer of corneal epithelium was obviously higher than that in the deep layers of corneal epithelium 30 minutes and 60 minutes after dosing.No fluorescence was observed in the cornea stroma of both eyes.
ConclusionsThe cornea epithelium is the main of absorption and distribution position of TH-NEs.The cornea stroma is the dominating permeation barrier for the intraocular transportation of the TH-NEs.The cornea stroma may stop the permeation of TH-NEs by molecular exclusion mechanism.
周天洋,夏慧芸,何继军,等. 盐酸特比萘芬纳米乳剂点眼经角膜途径的吸收及分布特征[J]. 中华实验眼科杂志,2015,33(10):910-914.
DOI:10.3760/cma.j.issn.2095-0160.2015.10.010版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。
除非特别声明,本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。